Denali Therapeutics has filed a notice of an exempt offering of securities to raise $499,732,711.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Denali Therapeutics is raising up to $499,732,711.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Ryan Watts…
